[Therapeutic problems in the application of antiparkinsonian drugs in psychiatry]

This paper describes therapeutic problems concerning antiparkinsonian drugs in psychiatry. Particular attention was paid to problems like: 1. Possibility of making a therapeutic mistake of too prolonged and therefore harmful pharmacotherapy with antiparkinsonian drugs in the treatment of most common psychoses. 2. The importance of a careful selection of an optimal antiparkinsonian drug, especially in psyhogeriatric cases (for example Amantadinum). 3. The description of other indications for antiparkinsonian drugs: affective diseases or alcoholic withdrawal syndroms.